Feature
The first export of Australian medicinal cannabis has deen delivered to the UK.
Australian firm Little Green Pharma has successfully exported its first shipment of medicinal cannabis products for patients into the UK.
The products will be distributed in the UK by Astral Health, a specialist importer and distributor of medicinal cannabis.
The products were imported under the purchase agreement between the company and Astral Health announced in February.
On 2 March, the UK Home Office and The Medicines and Healthcare products Regulatory Agency announced that import permits may now be granted based on anticipated prescription quantities.
LGP managing director Fleta Solomon said: “Little Green Pharma is one of a few companies with [good manufacturing practice]-produced cannabinoid medicines available in the UK.
“We are proud to be leading the charge in helping patients across the globe access quality Australian medicinal cannabis products.”
Australia’s Minister for Health, the Honourable Greg Hunt said:“This first export of Australian-produced medicinal cannabis oils to the UK marks an important step in fulfilling Australia’s vision of building a global medicinal cannabis industry capable of supplying quality medicinal cannabis products to both Australian and overseas patients.”
The UK industry is forecast to grow to £1.05bn by 2024, with an expected 400,000 patients being prescribed medicinal cannabis
Little Green Pharma’s operations cover cultivation, production, manufacturing and distribution.
The Company has an indoor cultivation facility in Western Australia.
A round-up of the latest science, regulation and developments across the UK and Europe — in your inbox every week.
A round-up of the latest science, regulation and developments across the UK and Europe — in your inbox every week.